Investing

Investing Cash Flow

Elevance Health Investing Cash Flow decreased by 34.2% to -$1.64B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1694.2%, from $103.00M to -$1.64B. Over 3 years (FY 2021 to FY 2024), Investing Cash Flow shows an upward trend with a -18.8% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026

How to read this metric

Typically negative for growing companies as they reinvest cash; a positive value suggests the company is liquidating assets faster than it is buying them.

Detailed definition

The aggregate sum of all cash inflows and outflows related to a company's long-term investments and capital assets. It s...

Peer comparison

Mature companies with high cash flow often show large negative values here as they recycle profits into new growth or financial instruments.

Metric ID: net_cash_from_investing

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value-$4.93B-$1.44B-$966.00M-$1.58B-$2.02B-$1.25B$0.00-$3.18B-$672.00M-$687.00M-$1.03B-$2.31B-$818.00M-$401.00M-$1.64B$103.00M-$687.00M-$1.22B-$1.64B
QoQ Change+70.8%+32.9%-63.4%-28.3%+38.4%+100.0%+78.9%-2.2%-49.8%-124.5%+64.6%+51.0%-308.5%+106.3%-767.0%-78.2%-34.2%
YoY Change+58.9%+13.4%+100.0%-101.8%+66.8%+44.9%+27.4%-21.7%+41.6%-59.2%+104.5%+16.0%-205.2%<-999%
Range-$4.93B$103.00M
CAGR-21.7%
Avg YoY Growth-114.9%
Median YoY Growth+21.7%
Current Streak3 quarters decline

Frequently Asked Questions

What is Elevance Health's investing cash flow?
Elevance Health (ELV) reported investing cash flow of -$1.64B in Q1 2026.
How has Elevance Health's investing cash flow changed year-over-year?
Elevance Health's investing cash flow decreased by 1694.2% year-over-year, from $103.00M to -$1.64B.
What is the long-term trend for Elevance Health's investing cash flow?
Over 3 years (2021 to 2024), Elevance Health's investing cash flow has grown at a -18.8% compound annual growth rate (CAGR), from -$9.64B to -$5.17B.
What does investing cash flow mean?
The total net change in cash resulting from buying and selling long-term assets and investments.